SERPINA1 and cystic fibrosis: Compared with healthy controls, the sera of CF patients displayed a 4.77-fold increase in the expression of alpha-1-antitrypsin (A1AT/SERPINA1), which is an inhibitor of serine proteases with NE being its primary target.